NATIONAL INSTITUTE ON DRUG ABUSE EPIDEMIOLOGIC ...
NATIONAL INSTITUTE ON DRUG ABUSE EPIDEMIOLOGIC ...
NATIONAL INSTITUTE ON DRUG ABUSE EPIDEMIOLOGIC ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
than age 18, compared to 4 percent of secondary intranasal<br />
cocaine users).<br />
Prices for powdered cocaine for the second half of<br />
2004 were reported as $20,000–$32,000 per kilogram<br />
at the wholesale level, $900–$1,200 per ounce at<br />
midlevel, and $20–$200 per gram at the retail level.<br />
Prices for crack cocaine were reported as $20,000–<br />
$26,000 per kilogram at the wholesale level, $600–<br />
$1,200 per ounce at midlevel, and $40–$200 per<br />
gram at the retail level. For powdered cocaine, the<br />
price range at the wholesale kilogram level was unchanged<br />
from the second half of 2003, while the<br />
lower limit for a retail-level gram was less. For crack<br />
cocaine, the lower limit for a wholesale kilogram was<br />
unchanged from the second half of 2003, while the<br />
lower limit for a retail-level gram was less.<br />
Heroin<br />
Heroin indicators for the Baltimore metropolitan area<br />
as a whole generally indicated an increase over 2001<br />
levels (exhibit 1). The rate of heroin ED mentions<br />
(203 per 100,000 population in 2002) represented a<br />
significant 4-percent increase from 195 per 100,000<br />
in 2001. The heroin treatment admission rate increased<br />
from 652 per 100,000 population age 12 and<br />
older in 2001 to 875 per 100,000 in 2003 (exhibit 2).<br />
However, it was projected to decline slightly to 858<br />
per 100,000 in 2004.<br />
Heroin use in the Baltimore metropolitan area is complex.<br />
There are several groups of heroin users differing<br />
by urbanicity, route of administration, age, and race. In<br />
the first half of 2004, the heroin treatment admission<br />
rate was about seven times higher in Baltimore City<br />
than in the suburban counties (exhibit 2).<br />
In Baltimore City, intranasal use was the preferred<br />
route of administration among treatment admissions<br />
(exhibit 2), and the admission rate for intranasal use<br />
was 29 percent higher than for injection. In the suburban<br />
counties, however, the rate for heroin injection<br />
was 63 percent higher than for inhalation.<br />
Exhibit 6 compares the number of treatment admissions<br />
in the first half of 2004 by route of administration,<br />
age, and race. Baltimore has a core of older African-American<br />
heroin users, both injectors and intranasal<br />
users. White users entering treatment for heroin<br />
were younger and were predominantly injectors.<br />
African-American heroin intranasal users made up 40<br />
percent of the heroin-using treatment admissions in<br />
the Baltimore PMSA in the first half of 2004. Most<br />
(85 percent) were treated in Baltimore City. Among<br />
22<br />
<strong>EPIDEMIOLOGIC</strong> TRENDS IN <strong>DRUG</strong> <strong>ABUSE</strong>—Baltimore Metropolitan Area<br />
heroin intranasal users in the city (exhibit 7), most<br />
admissions were African-American (91 percent) and<br />
were age 35 and older (74 percent). The proportion of<br />
intranasal users age 25 and younger decreased from 5<br />
percent in 2000 to 3 percent in the first half of 2004.<br />
Almost one-half (47 percent) of the intranasal heroin<br />
users in the city were women. The median age at admission<br />
was 39, and the median duration of use before<br />
first entering treatment was 14 years. Almost<br />
three-quarters (73 percent) reported daily heroin use.<br />
One-third (33 percent) entered treatment through the<br />
criminal justice system, and less than one-third (29<br />
percent) were receiving treatment for the first time.<br />
Almost three-quarters (72 percent) reported use of<br />
other drugs—45 percent smoked cocaine, 11 percent<br />
used cocaine intranasally, 26 percent used alcohol, 10<br />
percent used marijuana, and 2 percent used opiates<br />
other than heroin.<br />
White heroin injectors made up 26 percent of the<br />
heroin-using treatment admissions in the Baltimore<br />
PMSA in the first half of 2004. More than one-half<br />
(61 percent) were treated in the suburban counties.<br />
Among heroin injectors in the suburban counties (exhibit<br />
8), most admissions were White (81 percent).<br />
About one-third (34 percent) of suburban injectors<br />
were age 25 and younger. Sixty percent of the suburban<br />
heroin injectors were male. The median age at<br />
admission was 30, and the median duration of use<br />
before first entering treatment was 7 years. Almost<br />
three-quarters (74 percent) reported daily heroin use.<br />
Less than one in five (19 percent) entered treatment<br />
through the criminal justice system, and one-third (33<br />
percent) were receiving treatment for the first time.<br />
Two-thirds (67 percent) reported use of other drugs—<br />
14 percent smoked cocaine, 29 percent injected cocaine,<br />
20 percent used alcohol, 17 percent used marijuana,<br />
and 8 percent used opiates other than heroin.<br />
African-American heroin injectors made up 21 percent<br />
of the heroin-using treatment admissions in the<br />
Baltimore PMSA in the first half of 2004. Most (85<br />
percent) were treated in Baltimore City. Among heroin<br />
injectors in the city (exhibit 8), the majority of<br />
admissions (64 percent) were African-American and<br />
were age 35 and older (70 percent), although the proportion<br />
of intranasal users age 25 and younger increased<br />
slightly from 9 percent in 2000 to 11 percent<br />
in the first half of 2004. Some 44 percent of the city’s<br />
heroin injectors were women. The median age at admission<br />
was 40, and the median duration of use before<br />
first entering treatment was 17 years. Most (77<br />
percent) reported daily heroin use. Less than onequarter<br />
(23 percent) entered treatment through the<br />
criminal justice system, and less than one in five (22<br />
percent) were receiving treatment for the first time.<br />
Proceedings of the Community Epidemiology Work Group, Vol. II, January 2005